MXPA06013168A - Apparatus and method for transdermal delivery of parathyroid hormone agents. - Google Patents

Apparatus and method for transdermal delivery of parathyroid hormone agents.

Info

Publication number
MXPA06013168A
MXPA06013168A MXPA06013168A MXPA06013168A MXPA06013168A MX PA06013168 A MXPA06013168 A MX PA06013168A MX PA06013168 A MXPA06013168 A MX PA06013168A MX PA06013168 A MXPA06013168 A MX PA06013168A MX PA06013168 A MXPA06013168 A MX PA06013168A
Authority
MX
Mexico
Prior art keywords
transdermal delivery
parathyroid hormone
hormone agents
microprojection member
epidermis
Prior art date
Application number
MXPA06013168A
Other languages
Spanish (es)
Inventor
Yuh-Fun Maa
Peter Daddona
Mahmoud Ameri
Michael J N Cormier
Marika Kamberi
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of MXPA06013168A publication Critical patent/MXPA06013168A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0046—Solid microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061—Methods for using microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

An apparatus and method for transdermally delivering a biologically active agent comprising a delivery system having a microprojection member (or system) that includes a plurality of microprojections (or array thereof) that are adapted to pierce through the stratum corneum into the underlying epidermis layer, or epidermis and dermis layers. In one embodiment, the PTH-based agent is contained in a biocompatible coating that is applied to the microprojection member.
MXPA06013168A 2004-05-13 2005-03-18 Apparatus and method for transdermal delivery of parathyroid hormone agents. MXPA06013168A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US57130404P 2004-05-13 2004-05-13
US58527604P 2004-07-01 2004-07-01
US64366005P 2005-01-12 2005-01-12
PCT/US2005/009147 WO2005112984A2 (en) 2004-05-13 2005-03-18 Apparatus and method for transdermal delivery of parathyroid hormone agents

Publications (1)

Publication Number Publication Date
MXPA06013168A true MXPA06013168A (en) 2007-05-15

Family

ID=35428853

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06013168A MXPA06013168A (en) 2004-05-13 2005-03-18 Apparatus and method for transdermal delivery of parathyroid hormone agents.

Country Status (12)

Country Link
US (4) US7556821B2 (en)
EP (1) EP1744683B1 (en)
JP (2) JP5007427B2 (en)
AR (1) AR048887A1 (en)
AU (1) AU2005244734A1 (en)
BR (1) BRPI0509788A (en)
CA (1) CA2566032A1 (en)
ES (1) ES2568259T3 (en)
IL (1) IL179197A0 (en)
MX (1) MXPA06013168A (en)
NO (1) NO20065720L (en)
WO (1) WO2005112984A2 (en)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE234129T1 (en) * 1996-06-18 2003-03-15 Alza Corp DEVICE FOR IMPROVING TRANSDERMAL ADMINISTRATION OF MEDICATIONS OR EXTRACTION OF BODY FLUID
US7419481B2 (en) * 2000-10-13 2008-09-02 Alza Corporation Apparatus and method for piercing skin with microprotrusions
CZ20031037A3 (en) * 2000-10-13 2003-10-15 Alza Corporation Apparatus and method for piercing skin with microprotrusions
EP1333880B1 (en) * 2000-10-26 2009-04-15 Alza Corporation Transdermal drug delivery devices having coated microprotrusions
US20020193729A1 (en) * 2001-04-20 2002-12-19 Cormier Michel J.N. Microprojection array immunization patch and method
ATE336277T1 (en) * 2002-06-28 2006-09-15 Alza Corp METHOD FOR THE SURFACE COATING OF DEVICES FOR TRANSDERMAL ADMINISTRATION OF DRUGS WITH COATED MICROPROJECTIONS
WO2005044333A2 (en) 2003-10-31 2005-05-19 Alza Corporation Self-actuating applicator for microprojection array
US20050271684A1 (en) * 2004-04-13 2005-12-08 Trautman Joseph C Apparatus and method for transdermal delivery of multiple vaccines
BRPI0509788A (en) * 2004-05-13 2007-10-23 Alza Corp apparatus and method for transdermal delivery of parathyroid hormone agents
CA2579509A1 (en) * 2004-09-08 2006-03-16 Alza Corporation Microprojection array with improved skin adhesion and compliance
WO2007033015A1 (en) * 2005-09-12 2007-03-22 Alza Corporation Coatable transdermal delivery microprojection assembly
AU2006315132A1 (en) * 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
US8900180B2 (en) * 2005-11-18 2014-12-02 3M Innovative Properties Company Coatable compositions, coatings derived therefrom and microarrays having such coatings
WO2007084247A2 (en) * 2005-12-28 2007-07-26 Alza Corporation Stable therapeutic formulations
US9339641B2 (en) 2006-01-17 2016-05-17 Emkinetics, Inc. Method and apparatus for transdermal stimulation over the palmar and plantar surfaces
US9610459B2 (en) 2009-07-24 2017-04-04 Emkinetics, Inc. Cooling systems and methods for conductive coils
CN101466393A (en) * 2006-03-15 2009-06-24 阿尔扎公司 Method for transdermal delivery of parathyroid hormone agents to prevent or treat osteopenia
WO2007127815A2 (en) * 2006-04-25 2007-11-08 Alza Corporation Microprojection array application with multilayered microprojection member for high drug loading
WO2007127811A2 (en) * 2006-04-25 2007-11-08 Alza Corporation Microprojection array application with grouped microprojections for high drug loading
WO2008042902A2 (en) 2006-10-02 2008-04-10 Emkinetics, Inc. Method and apparatus for magnetic induction therapy
US9005102B2 (en) 2006-10-02 2015-04-14 Emkinetics, Inc. Method and apparatus for electrical stimulation therapy
US10786669B2 (en) 2006-10-02 2020-09-29 Emkinetics, Inc. Method and apparatus for transdermal stimulation over the palmar and plantar surfaces
US11224742B2 (en) 2006-10-02 2022-01-18 Emkinetics, Inc. Methods and devices for performing electrical stimulation to treat various conditions
ES2820335T3 (en) 2007-04-16 2021-04-20 Corium Inc Solvent Cast Microneedle Arrays Containing Active Agent
WO2009048607A1 (en) 2007-10-10 2009-04-16 Corium International, Inc. Vaccine delivery via microneedle arrays
JP2011524345A (en) * 2008-06-04 2011-09-01 コーダ セラピューティクス， インコーポレイテッド Treatment of pain with gap junction modulating compounds
US20110288485A1 (en) * 2008-12-26 2011-11-24 Hisamitsu Pharmaceutical Co., Inc. Microneedle device
US20100226966A1 (en) * 2009-03-03 2010-09-09 Daddona Peter E Method for transdermal controlled release drug delivery
US20100286600A1 (en) * 2009-05-08 2010-11-11 Bommannan D Bommi Transdermal patch device
JP2013508119A (en) 2009-10-26 2013-03-07 エムキネティクス， インコーポレイテッド Method and apparatus for electromagnetic stimulation of nerves, muscles and body tissues
EP2509996A1 (en) 2009-12-07 2012-10-17 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
US20130041330A1 (en) 2010-02-24 2013-02-14 Hisamitsu Pharmaceutical Co., Inc. Micro-needle device and preparation method
EP2566501B1 (en) * 2010-05-04 2019-03-13 Corium International, Inc. Method and device for transdermal delivery of parathyroid hormone using a microprojection array
RS54993B1 (en) 2010-05-12 2016-11-30 Radius Health Inc Therapeutic regimens
US8588884B2 (en) 2010-05-28 2013-11-19 Emkinetics, Inc. Microneedle electrode
ES2550319T3 (en) 2010-09-28 2015-11-06 Radius Health, Inc Selective androgen receptor modulators
WO2012075375A1 (en) * 2010-12-02 2012-06-07 Lanco Biosciences, Inc. Delivery of parathyroid hormones by microinjection systems
WO2012115208A1 (en) 2011-02-24 2012-08-30 久光製薬株式会社 Glp-1 analogue composition for microneedle devices
WO2012115207A1 (en) * 2011-02-24 2012-08-30 久光製薬株式会社 Biologically active nonaqueous composition for microneedle devices, and biologically active nonaqueous composition adhering to microneedle
WO2012145665A2 (en) 2011-04-22 2012-10-26 Radius Health, Inc. Method of drug delivery for pth, pthrp and related peptides
CN108195965B (en) 2011-06-07 2021-02-23 旭化成制药株式会社 Method for testing PTH peptide-containing lyophilized preparation, and method for producing pharmaceutical product containing PTH peptide-containing lyophilized preparation
US10980865B2 (en) 2012-08-10 2021-04-20 Aquavit Pharmaceuticals, Inc. Direct application system and method for the delivery of bioactive compositions and formulations
US9173598B1 (en) * 2012-08-27 2015-11-03 Abdullah Khalid Al Rasheed Device for piercing the skin to obtain a blood sample and method of use
WO2014034882A1 (en) * 2012-08-30 2014-03-06 帝人株式会社 Microneedle array coated with drug composition
MX2015008157A (en) 2012-12-21 2016-02-22 Corium Int Inc Microarray for delivery of therapeutic agent and methods of use.
US9775799B2 (en) 2013-02-13 2017-10-03 Hisamitsu Pharmaceutical Co., Inc. Microneedle-coating composition and microneedle device
EP2957298B1 (en) 2013-02-13 2018-11-28 Hisamitsu Pharmaceutical Co., Inc. Microneedle coating composition and microneedle device
JP6081215B2 (en) * 2013-02-13 2017-02-15 久光製薬株式会社 Coating and microneedle devices
CN105142711B (en) 2013-03-12 2019-01-22 考里安国际公司 Micro-protuberance applicator
EP4194028A1 (en) 2013-03-15 2023-06-14 Corium Pharma Solutions, Inc. Multiple impact microprojection applicators
JP2016514133A (en) 2013-03-15 2016-05-19 コリウム インターナショナル， インコーポレイテッド MICROARRAY CONTAINING FINE STRUCTURE CONTAINING NO POLYMER, MANUFACTURING METHOD AND USE METHOD
ES2908339T3 (en) 2013-03-15 2022-04-28 Corium Inc Microarray for delivery of a therapeutic agent and methods of use
WO2015017561A1 (en) 2013-07-30 2015-02-05 Zosano Pharma, Inc. Low-profile microneedle patch applicator
JP5728553B2 (en) 2013-10-18 2015-06-03 ユニ・チャーム株式会社 Non-woven fabric bulk recovery device and non-woven fabric bulk recovery method
JP5728552B2 (en) 2013-10-18 2015-06-03 ユニ・チャーム株式会社 Non-woven fabric bulk recovery device and non-woven fabric bulk recovery method
EP3188714A1 (en) 2014-09-04 2017-07-12 Corium International, Inc. Microstructure array, methods of making, and methods of use
WO2016081616A2 (en) * 2014-11-18 2016-05-26 4P Therapeutics Transdermal patch formulations for delivery of water soluble drugs, peptides, proteins and oligosaccharides
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9375478B1 (en) 2015-01-30 2016-06-28 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
BR112017023269A2 (en) 2015-04-29 2018-11-06 Radius Pharmaceuticals Inc methods for cancer treatment
US10857093B2 (en) 2015-06-29 2020-12-08 Corium, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
EP3359129B1 (en) * 2015-10-09 2022-02-23 Kindeva Drug Delivery L.P. Zinc compositions for coated microneedle arrays
WO2017137402A1 (en) * 2016-02-08 2017-08-17 Lunaphore Technologies Sa Methods of sample cycle multiplexing and in situ imaging
US9918932B2 (en) 2016-02-19 2018-03-20 Zosano Pharma Corporation Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines
CA3020333A1 (en) * 2016-04-18 2017-10-26 Radius Health, Inc. Formulations of abaloparatide, transdermal patches thereof, and uses thereof
CA3027563A1 (en) 2016-06-22 2017-12-28 Radius Health, Inc. Ar+ breast cancer treatment methods
US10385008B2 (en) 2017-01-05 2019-08-20 Radius Pharmaceuticals, Inc. Polymorphic forms of RAD1901-2HCL
CA3223555A1 (en) 2017-08-23 2019-02-28 Emergex USA Corporation Method of rapidly achieving therapeutic concentrations of zolmitriptan for treatment of migraines and cluster headaches
US11660264B2 (en) 2017-08-23 2023-05-30 Emergex USA Corporation Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
CA3075977A1 (en) * 2017-09-22 2019-03-28 Asahi Kasei Pharma Corporation Teriparatide-containing liquid pharmaceutical composition having excellent stability
US11660265B2 (en) 2018-06-28 2023-05-30 Emergex USA Corporation Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
CN112423844A (en) 2018-07-04 2021-02-26 雷迪厄斯制药公司 Polymorphic forms of RAD1901-2HCL

Family Cites Families (120)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE25637E (en) 1964-09-08 Means for vaccinating
US3123212A (en) 1964-03-03 Multiple disposable intracutaneous injector package
US2619962A (en) 1948-02-19 1952-12-02 Res Foundation Vaccination appliance
US2893392A (en) 1958-01-08 1959-07-07 American Cyanamid Co Article of manufacture for intracutaneous injections
US3072122A (en) 1959-01-15 1963-01-08 Rosenthal Sol Roy Package for transcutaneous injection
US3221739A (en) 1962-03-26 1965-12-07 Rosenthal Sol Roy Injection device
US3221740A (en) 1962-08-31 1965-12-07 Rosenthal Sol Roy Injection device
US3964482A (en) 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
US3678150A (en) 1971-07-27 1972-07-18 American Cyanamid Co Process for improving the stability of ppd, qt and histoplasmin on tine applicators
BE795384A (en) 1972-02-14 1973-08-13 Ici Ltd DRESSINGS
US4086196A (en) 1975-03-28 1978-04-25 Armour Pharmaceutical Company Parathyroid hormone
IL78342A (en) 1985-04-04 1991-06-10 Gen Hospital Corp Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof
SE8501990D0 (en) 1985-04-24 1985-04-24 Pharmacia Ab BELEGGNINGSFORFARANDE
US5420242A (en) 1986-10-22 1995-05-30 Kaare M. Gautvik Production of human parathyroid hormone from microorganisms
US4833125A (en) 1986-12-05 1989-05-23 The General Hospital Corporation Method of increasing bone mass
US5080646A (en) 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
DE3722775A1 (en) 1987-07-09 1989-01-19 Lohmann Therapie Syst Lts TRANSDERMAL THERAPEUTIC SYSTEM
US5527772A (en) 1987-10-20 1996-06-18 Holick; Michael F. Regulation of cell proliferation and differentiation using peptides
US5147296A (en) 1988-10-03 1992-09-15 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5169382A (en) 1988-10-03 1992-12-08 Alza Corporation Membrane for electrotransport transdermal drug delivery
EP0429842B1 (en) 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
US5279544A (en) 1990-12-13 1994-01-18 Sil Medics Ltd. Transdermal or interdermal drug delivery devices
US5208041A (en) 1991-05-23 1993-05-04 Allelix Biopharmaceuticals Inc. Essentially pure human parathyroid hormone
US5563122A (en) 1991-12-09 1996-10-08 Asahi Kasei Kogyo Kabushiki Kaisha Stabilized parathyroid hormone composition
US5629019A (en) * 1992-02-27 1997-05-13 Alza Corporation Formulations with hydrophobic permeation enhancers
US5225098A (en) * 1992-03-20 1993-07-06 The Procter & Gamble Company Neutral pH freezer bar and process
US5382658A (en) 1992-04-03 1995-01-17 Allelix Biopharmaceuticals Inc. Stability-enhanced variants of parathyroid hormone
AU672790B2 (en) 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
IT1255723B (en) 1992-10-09 1995-11-13 USE OF PARATORMONE, ITS BIOLOGICALLY ACTIVE FRAGMENTS AND RELATED PEPTIDES, FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS USEFUL IN THE PREVENTION AND THERAPY OF ABORTION AND PRETERMONE BIRTH AND IN GENERAL FOR THE TREATMENT OF GESTATION
DE69401336T2 (en) * 1993-01-21 1997-04-24 Janssen Pharmaceutica Nv TOPICAL KETOCONAZOLE MEDICINAL PRODUCT
JP3628713B2 (en) * 1993-06-07 2005-03-16 帝國製薬株式会社 Vaginal preparation containing physiologically active peptide
TW303299B (en) 1993-07-22 1997-04-21 Lilly Co Eli
US5679647A (en) * 1993-08-26 1997-10-21 The Regents Of The University Of California Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
DE4341444C2 (en) 1993-12-04 1996-03-14 Lohmann Therapie Syst Lts Active substance-containing plaster and process for its production
US5496801A (en) * 1993-12-23 1996-03-05 Allelix Biopharmaceuticals Inc. Parathyroid hormone formulation
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
AU4282096A (en) * 1994-11-15 1996-06-06 Osmotics Corporation Skin care compositions and methods
US5747456A (en) 1994-12-19 1998-05-05 Beth Israel Deaconess Medical Center Continuous low-dose administration of parathyroid hormone or its agonist
CA2210095A1 (en) 1995-01-14 1996-07-18 Jochen Daume Heat-transfer concentrate, method of manufacturing it and its use, as well as a latent-heat accumulator making use of the concentrate
US5550134A (en) 1995-05-10 1996-08-27 Eli Lilly And Company Methods for inhibiting bone loss
AU5869796A (en) 1995-05-22 1996-12-11 Ned A. Godshall Micromechanical patch for enhancing the delivery of compound s through the skin
AU5740496A (en) 1995-05-22 1996-12-11 General Hospital Corporation, The Micromechanical device and method for enhancing delivery of compounds through the skin
US5599822A (en) 1995-06-06 1997-02-04 Eli Lilly And Company Methods for minimizing bone loss
EP1166796A3 (en) 1996-02-01 2002-03-06 Chugai Seiyaku Kabushiki Kaisha Agents for preventing and treating thrombocytopenia
US5935607A (en) 1996-02-15 1999-08-10 Hadasit Medical Research Services And Development Company Ltd. Treatment of osteoporosis
ATE234129T1 (en) 1996-06-18 2003-03-15 Alza Corp DEVICE FOR IMPROVING TRANSDERMAL ADMINISTRATION OF MEDICATIONS OR EXTRACTION OF BODY FLUID
US5741554A (en) 1996-07-26 1998-04-21 Bio Dot, Inc. Method of dispensing a liquid reagent
US5916524A (en) 1997-07-23 1999-06-29 Bio-Dot, Inc. Dispensing apparatus having improved dynamic range
US5738728A (en) 1996-07-26 1998-04-14 Bio Dot, Inc. Precision metered aerosol dispensing apparatus
US5743960A (en) 1996-07-26 1998-04-28 Bio-Dot, Inc. Precision metered solenoid valve dispenser
WO1998004591A1 (en) 1996-07-31 1998-02-05 The General Hospital Corporation Novel parathyroid hormone-related peptide analogs
JP4054381B2 (en) 1996-09-17 2008-02-27 デカ・プロダクツ・リミテッド・パートナーシップ Drug delivery system by transfer
US6239144B1 (en) 1997-04-03 2001-05-29 Eli Lilly And Company Methods of treating bone loss
IL120943A (en) 1997-05-29 2004-03-28 Univ Ben Gurion Transdermal delivery system
EP1030658A1 (en) 1997-10-14 2000-08-30 Eli Lilly And Company Method of building and maintaining bone
US6770623B1 (en) 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
US6918901B1 (en) 1997-12-10 2005-07-19 Felix Theeuwes Device and method for enhancing transdermal agent flux
EP1035889B1 (en) 1997-12-11 2002-07-31 Alza Corporation Device for enhancing transdermal agent flux
ES2314995T3 (en) 1997-12-11 2009-03-16 Alza Corporation DEVICE FOR IMPROVING THE FLOW OF TANSDERMIC AGENTS.
US6083196A (en) 1997-12-11 2000-07-04 Alza Corporation Device for enhancing transdermal agent flux
EP0922467A3 (en) * 1997-12-12 2000-05-24 Takeda Chemical Industries, Ltd. Iontophoretic drug delivery
KR20010033268A (en) 1997-12-18 2001-04-25 피터 지. 스트링거 Crystalline Teriparatide
US6091975A (en) 1998-04-01 2000-07-18 Alza Corporation Minimally invasive detecting device
DZ2873A1 (en) 1998-08-19 2003-12-15 Lilly Co Eli Method for increasing bone hardness and stiffness.
US20040033950A1 (en) 2000-09-26 2004-02-19 Hock Janet M. Method of increasing bone toughness and stiffness and reducing fractures
ATE280615T1 (en) * 1998-08-31 2004-11-15 Johnson & Johnson Consumer ELECTRIC TRANSPORT DEVICE WITH BLADES
CA2245903A1 (en) 1998-09-28 2000-03-28 Mcgill University Use of pex in the treatment of metabolic bone diseases
WO2000019823A1 (en) 1998-10-07 2000-04-13 The Board Of Trustees Of The University Of Arkansas Methods of screening for apoptosis-controlling agents for bone anabolic therapies and uses thereof
DE69938064T2 (en) 1998-11-25 2009-01-15 The General Hospital Corp., Boston AMINOTERMINAL MODIFIED PARATHYROIDHORMONE (PTH) ANALOG
US6884427B1 (en) 1999-02-08 2005-04-26 Aderans Research Institute, Inc. Filamentary means for introducing agents into tissue of a living host
US6743211B1 (en) 1999-11-23 2004-06-01 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
US6379324B1 (en) 1999-06-09 2002-04-30 The Procter & Gamble Company Intracutaneous microneedle array apparatus
US6256533B1 (en) 1999-06-09 2001-07-03 The Procter & Gamble Company Apparatus and method for using an intracutaneous microneedle array
EP1222465A1 (en) 1999-09-20 2002-07-17 Eli Lilly And Company Method for monitoring treatment with a parathyroid hormone
CA2383574A1 (en) 1999-09-20 2001-03-29 Eli Lilly And Company Method for reducing the risk of cancer
US6623457B1 (en) 1999-09-22 2003-09-23 Becton, Dickinson And Company Method and apparatus for the transdermal administration of a substance
US6835184B1 (en) 1999-09-24 2004-12-28 Becton, Dickinson And Company Method and device for abrading skin
US20020095134A1 (en) 1999-10-14 2002-07-18 Pettis Ronald J. Method for altering drug pharmacokinetics based on medical delivery platform
US8465468B1 (en) * 2000-06-29 2013-06-18 Becton, Dickinson And Company Intradermal delivery of substances
KR100452972B1 (en) * 2000-05-16 2004-10-14 주식회사 삼양사 Hydrogel composition for transdermal drug
US6565532B1 (en) 2000-07-12 2003-05-20 The Procter & Gamble Company Microneedle apparatus used for marking skin and for dispensing semi-permanent subcutaneous makeup
US6537242B1 (en) 2000-06-06 2003-03-25 Becton, Dickinson And Company Method and apparatus for enhancing penetration of a member for the intradermal sampling or administration of a substance
US20050008683A1 (en) 2000-06-29 2005-01-13 Becton Dickinson And Company Method for delivering interferons to the intradermal compartment
US6589202B1 (en) 2000-06-29 2003-07-08 Becton Dickinson And Company Method and apparatus for transdermally sampling or administering a substance to a patient
US6440096B1 (en) 2000-07-14 2002-08-27 Becton, Dickinson And Co. Microdevice and method of manufacturing a microdevice
GB0017999D0 (en) 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
KR100818545B1 (en) 2000-10-13 2008-04-01 알자 코포레이션 Microblade array impact applicator
CA2425312C (en) * 2000-10-13 2010-02-16 Alza Corporation Microprotrusion member retainer for impact applicator
CZ20031037A3 (en) 2000-10-13 2003-10-15 Alza Corporation Apparatus and method for piercing skin with microprotrusions
EP1333880B1 (en) 2000-10-26 2009-04-15 Alza Corporation Transdermal drug delivery devices having coated microprotrusions
EP1345646A2 (en) 2000-12-14 2003-09-24 Georgia Tech Research Corporation Microneedle devices and production thereof
US6855372B2 (en) 2001-03-16 2005-02-15 Alza Corporation Method and apparatus for coating skin piercing microprojections
US20020193729A1 (en) 2001-04-20 2002-12-19 Cormier Michel J.N. Microprojection array immunization patch and method
DE60233939D1 (en) * 2001-04-20 2009-11-19 Alza Corp MICROPROJECTION ARRANGEMENT WITH A COATING CONTAINING ADVANTAGEOUS MEDIUM
US6881203B2 (en) 2001-09-05 2005-04-19 3M Innovative Properties Company Microneedle arrays and methods of manufacturing the same
WO2003026733A2 (en) 2001-09-28 2003-04-03 Biovalve Technologies, Inc. Microneedle with membrane
US6689100B2 (en) 2001-10-05 2004-02-10 Becton, Dickinson And Company Microdevice and method of delivering or withdrawing a substance through the skin of an animal
AU2002363412A1 (en) 2001-11-05 2003-05-19 Eli Lilly And Company Method for improving stability of a bone-connecting implant
AU2002352978A1 (en) 2001-11-30 2003-06-17 Alza Corporation Methods and apparatuses for forming microprojection arrays
PT1465535E (en) 2001-12-20 2008-02-08 Alza Corp Skin-piercing microprojections having piercing depth control
US7015262B2 (en) 2002-05-01 2006-03-21 Lifescan, Inc. Hydrophilic coatings for medical implements
AU2003239869A1 (en) 2002-05-23 2003-12-12 Michael Holick Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy
ATE336277T1 (en) 2002-06-28 2006-09-15 Alza Corp METHOD FOR THE SURFACE COATING OF DEVICES FOR TRANSDERMAL ADMINISTRATION OF DRUGS WITH COATED MICROPROJECTIONS
US20040115167A1 (en) * 2002-09-30 2004-06-17 Michel Cormier Drug delivery device and method having coated microprojections incorporating vasoconstrictors
AR042815A1 (en) 2002-12-26 2005-07-06 Alza Corp ACTIVE AGENT SUPPLY DEVICE THAT HAS COMPOUND MEMBERS
JP5456234B2 (en) * 2003-06-30 2014-03-26 アルザ・コーポレーシヨン Formulations for coated microprojections containing non-volatile counterions
US20050123507A1 (en) * 2003-06-30 2005-06-09 Mahmoud Ameri Formulations for coated microprojections having controlled solubility
EP1638468B1 (en) 2003-06-30 2007-08-15 Alza Corporation Method for coating skin piercing microprojections
JP2006528327A (en) * 2003-07-10 2006-12-14 アクチボラゲット エス ケイ エフ Bearing unit with brazing or solder joint
BRPI0412664A (en) 2003-07-15 2006-09-26 Ca Nat Research Council A method for treating a condition characterized by hyperproliferation of skin cells in an at-risk or at-risk individual and using a therapeutically effective amount of a human parathyroid hormone (hpth) cyclic analogue.
KR20060115716A (en) * 2003-08-04 2006-11-09 알자 코포레이션 Method and device for enhancing transdermal agent flux
EP1680057A4 (en) * 2003-10-24 2007-10-31 Alza Corp Apparatus and method for enhancing transdermal drug delivery
JP2007535337A (en) * 2003-10-28 2007-12-06 アルザ・コーポレーシヨン Delivery of therapeutic peptide and protein polymer conjugates by coated microprojections
WO2005044333A2 (en) 2003-10-31 2005-05-19 Alza Corporation Self-actuating applicator for microprojection array
US20050106209A1 (en) * 2003-11-13 2005-05-19 Mahmoud Ameri Composition and apparatus for transdermal delivery
EP1557176A1 (en) 2004-01-26 2005-07-27 Ferring B.V. Treatment of bone metastases by means of PTH receptor agonists
BRPI0509788A (en) * 2004-05-13 2007-10-23 Alza Corp apparatus and method for transdermal delivery of parathyroid hormone agents
US20070213272A1 (en) 2004-07-14 2007-09-13 Katsuhiko Sato Transmucosal Administration Agent Containing Pth
CA2586856C (en) 2004-11-11 2015-04-07 The General Hospital Corporation Parathyroid hormone receptor activation and stem and progenitor cell expansion
WO2006083681A2 (en) 2005-01-31 2006-08-10 Alza Corporation Coated microprojections having reduced variability and method for producing same

Also Published As

Publication number Publication date
IL179197A0 (en) 2007-03-08
US20050256045A1 (en) 2005-11-17
US20100119568A1 (en) 2010-05-13
AU2005244734A1 (en) 2005-12-01
WO2005112984A3 (en) 2006-04-20
US20100152649A1 (en) 2010-06-17
JP2007536988A (en) 2007-12-20
WO2005112984A2 (en) 2005-12-01
US8633159B2 (en) 2014-01-21
ES2568259T3 (en) 2016-04-28
EP1744683A4 (en) 2010-09-29
EP1744683A2 (en) 2007-01-24
CA2566032A1 (en) 2005-12-01
NO20065720L (en) 2007-02-13
US7556821B2 (en) 2009-07-07
JP2012097087A (en) 2012-05-24
AR048887A1 (en) 2006-06-07
JP5007427B2 (en) 2012-08-22
EP1744683B1 (en) 2016-03-16
BRPI0509788A (en) 2007-10-23
JP5309203B2 (en) 2013-10-09
US9295714B2 (en) 2016-03-29
US20100160895A1 (en) 2010-06-24
US8361022B2 (en) 2013-01-29

Similar Documents

Publication Publication Date Title
MXPA06013168A (en) Apparatus and method for transdermal delivery of parathyroid hormone agents.
EP2001453A4 (en) Apparatus and method for transdermal delivery of parathyroid hormone agents to prevent or treat osteopenia
TW200602099A (en) Apparatus and method for transdermal delivery of fentanyl-based agents
TW200600132A (en) Frequency assisted transdermal agent delivery method and system
TW200616660A (en) Apparatus and method for transdermal delivery of natriuretic peptides
WO2005099751A3 (en) Apparatus and method for transdermal delivery of influenza vaccine
TW200618830A (en) Micorprojection apparatus and system with low infection potential
TW200600107A (en) Apparatus and method for transdermal delivery of multiple vaccines
WO2005051455A3 (en) Ultrasound assisted transdermal vaccine delivery method and system
TW200502017A (en) Active agent delivery device having composite members
TW200517156A (en) Pretreatment method and system for enhancing transdermal drug delivery
TW200621316A (en) Apparatus and method for transdermal delivery of vascular endothelial growth factors
MXPA03003815A (en) Transdermal drug delivery devices having coated microprotrusions.
WO2004030743A3 (en) Drug delivery device having coated microprojections incorporating vasoconstrictors
WO2004105729A3 (en) Transdermal vaccine delivery device having coated microprotrusions
TW200613029A (en) System and method for drug delivery and microfluidic applications using microneedles
AR047229A1 (en) ADMINISTRATION OF POLYMERIC CONJUGATES OF PEPTIDES AND THERAPEUTIC PROTEINS BY MEANS OF COVERED MICROPROJECTIONS
WO2007011788A3 (en) Skin penetrating device and method of use
JP2006525316A5 (en)
TW200605929A (en) Method and apparatus for reducing the incidence of tobacco use
EA200601129A1 (en) METHOD OF TREATMENT OF UNDESIRABLE EFFECT IN TRANSACTION DELIVERY OF THE MEDICINE (OPTIONS)
TW200738252A (en) Apparatus and method for transdermal delivery of Epoetin-based agents
CA2569285A1 (en) Methods of device-assisted drug delivery
TW200602019A (en) Apparatus and method for transdermal delivery of parathyroid hormone agents
WO2006113796A3 (en) Microbial cellulose materials for use in transdermal drug delivery system